Group 1: Financial Performance - The company's revenue in the first half of 2025 increased by 19.72% year-on-year, driven primarily by the performance of adult toothpaste and the growth of e-commerce channels [3][4] - Sales expenses grew by 44.89%, mainly directed towards enhancing e-commerce platform promotions, resulting in significant improvements in revenue scale and operational efficiency [3] - The gross margin of the e-commerce channel improved due to product structure optimization and operational efficiency enhancements [7] Group 2: Cost Reduction and Efficiency - The company is focused on cost reduction and efficiency improvement through strategies such as end-to-end collaboration, lean management, and data-driven decision-making [2][3] - Continuous implementation of cost reduction measures aims to create value for investors [2] Group 3: Product Development and Innovation - The company plans to enhance its product structure and iterate categories, transitioning from traditional toothpaste and toothbrushes to smart oral care products to increase overall customer value and profitability [4][5] - R&D expenditure remains stable at 3%-3.5%, focusing on three key technology areas: sensitivity solutions, modernization of traditional Chinese medicine applications, and smart innovations in electric oral care products [5][6] Group 4: Market Strategy and Growth - The company aims to develop four key business areas: oral care, smart oral care, oral medical, and innovative businesses, with a dynamic resource allocation strategy to support collaborative growth across these sectors [6] - The "7-Day Special Repair Toothpaste" is positioned as a high-end product, with plans to maintain growth momentum through enhanced online and offline channel integration [3][4] Group 5: Future Outlook and Shareholder Returns - The company is committed to a stable dividend policy, responding to regulatory calls for improved investor returns while ensuring sustainable profit distribution based on business performance [7] - The company anticipates continued growth in the oral medical and beauty care product lines, with a projected growth rate of 54.85% [5]

Core Viewpoint - The company, Chongqing Dengkang Oral Care Products Co., Ltd., has released its 2024 annual report, highlighting its financial performance, operational strategies, and future development plans. Company Overview - The company is transitioning from a traditional manufacturing entity to a comprehensive solution provider, driven by innovations in biotechnology, artificial intelligence, cloud computing, big data, 5G, and the Internet of Things [4][12]. - The company emphasizes a dual-driven growth model combining organic growth and external expansion [4]. Financial Performance - For the year 2024, the company achieved a consolidated revenue of CNY 1,560,070,850.25, representing a year-on-year increase of 13.40% [34]. - The net profit attributable to shareholders was CNY 161,179,433.51, reflecting a growth of 14.07% compared to the previous year [34]. Profit Distribution - The board approved a profit distribution plan, proposing a cash dividend of CNY 7.50 per 10 shares, totaling CNY 129,130,350.00, with no bonus shares issued [24][25]. Research and Development - The company adopts a "marketing + R&D" dual-driven development strategy, focusing on market needs and maintaining a technology innovation system [5][7]. - It has established a collaborative innovation ecosystem with various universities and research institutions to enhance its technological capabilities [8]. Sales and Marketing Strategy - The company has developed a marketing network that includes distribution, direct supply, and e-commerce models, effectively reaching consumers across various channels [11][12]. - The strategy aims to enhance brand awareness and market penetration, supporting the growth of the oral health industry [12]. Governance and Compliance - The board of directors has ensured compliance with relevant laws and regulations, maintaining transparency and accountability in its operations [19][21]. - The company has also approved the continuation of its auditing firm, Xinyong Zhonghe, for the 2025 fiscal year [30].